Publication | Open Access
Preclinical validation of AXL receptor as a target for antibody-based pancreatic cancer immunotherapy
104
Citations
29
References
2013
Year
Preclinical ValidationPancreatic CancerAxl ReceptorImmunologyImmune Checkpoint InhibitorImmunotherapyMedicineRadiation Oncology
| Year | Citations | |
|---|---|---|
Page 1
Page 1